Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation. [electronic resource]
Producer: 19970224Description: 1225-8 p. digitalISSN:- 0149-5992
- Albuminuria
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Cardiovascular Diseases -- prevention & control
- Diabetes Mellitus, Type 1 -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Angiopathies -- prevention & control
- Diabetic Nephropathies -- epidemiology
- Factor Analysis, Statistical
- Humans
- Middle Aged
- Placebos
- Ramipril -- therapeutic use
- Research Design
- Risk Factors
- Time Factors
- Vitamin E -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.